Dartmouth-Hitchcock Medical Center
Locations
Transplant Summary
Overview
The DHMC Transplant Program is performing autologous and allogeneic (HAPLO, MRD, and MUD) and is FACT accredited. Our program provides virtually all types of bone marrow and blood stem cell transplants for the treatment of lymphoma, leukemia, multiple myeloma and other tumors, as well as inpatient and outpatient treatment services.This center has been performing allogeneic transplants since 1994 and has been an NMDP transplant center since July 2006.
Attending physicians
Adult - Elizabeth Bengtson, Christi Hayes, John Hill, Frederick Lansigan, Raphael Lizcano, Kenneth Meehan, Swaroopa PonnamReddy, Parth Shah, Matthew SullivanTransplants performed
Marrow/PBSC onlyCord blood transplants
Not performedOther programs and services
Rest Easy Program, discounts at local lodging facilities
Patient-reported outcomes research
Social Worker and psychologist to help transplant patients during their journey
Assigned Transplant & Cellular Therapy RN Coordinator to navigate patients/caregivers to and through transplant
Philanthropy funds for hotel vouchers in some instances
Philanthropy funds for gas cards for patients traveling a distancePatient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 59 patients.The actual 1-year survival of these patients is 79.6%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 67.4% and 87.9%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
109
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow0PBSC9Cord blood0Total9Unrelated donorMarrow0PBSC35Cord blood0Total35Total allogeneicMarrow0PBSC44Cord blood0Total44AutologousMarrowBoth marrow & PBSC 65PBSC—Cord blood—Total65Total combinedMarrowBoth marrow & PBSC 109PBSC—Cord blood0Total109All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44045-64165+8Total9Unrelated 0-18019-44345-642165+11Total35Autologous 0-18019-44945-642965+27Total65Total 0-18019-441245-645165+46Total109Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Dartmouth Hitchcock Medical Center
1 Medical Center Dr. Lebanon, NH 3756 Phone:603-650-4628 For more information about this program: https://cancer.dartmouth.edu/blood-marrow.html (Opens in a new tab)Overview
Our program offers follow-up patient care, including assessment of late complications of HSCT, routine health screening, family or genetic counseling as indicated, psychosocial needs, and referral to specialists as indicated.
Staff
Program Director:Kenneth R. Meehan, MDProgram Coordinator:Kate Caldon, RNMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 3 months auto, 1 yr allo after transplant.
- Adults (over age 16)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital